SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 71 filers reported holding SILVERBACK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $80,000 | -30.4% | 15,057 | -44.3% | 0.01% | -33.3% |
Q2 2022 | $115,000 | -10.2% | 27,022 | -25.6% | 0.01% | -18.2% |
Q1 2022 | $128,000 | -67.0% | 36,331 | -37.7% | 0.01% | -67.6% |
Q4 2021 | $388,000 | +132.3% | 58,304 | +247.8% | 0.03% | +70.0% |
Q3 2021 | $167,000 | – | 16,765 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,618,036 | $80,871,000 | 3.02% |
Orbimed Advisors | 8,740,887 | $270,006,000 | 2.73% |
Boxer Capital, LLC | 1,675,377 | $51,752,000 | 1.83% |
Endurant Capital Management LP | 139,124 | $4,298,000 | 1.18% |
Nantahala Capital Management | 1,266,266 | $39,115,000 | 1.11% |
COMMODORE CAPITAL LP | 97,143 | $3,001,000 | 1.05% |
Ally Bridge Group (NY) LLC | 128,572 | $3,972,000 | 0.99% |
RA Capital Management | 1,742,186 | $53,816,000 | 0.86% |
HighVista Strategies LLC | 25,906 | $800,000 | 0.57% |
SPHERA FUNDS MANAGEMENT LTD. | 173,891 | $5,371,000 | 0.36% |